Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 4
2009 1
2010 4
2011 4
2013 2
2015 2
2016 3
2017 4
2018 2
2019 2
2020 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series.
Wieczorek M, Mariotto S, Ferrari S, Mosna F, Micò MC, Borghero C, Dubbini MV, Malagola M, Skert C, Andreini A, De Marco B, Polo D, Tfaily A, Krampera M, Grassi A, Candoni A, Ranzato F, Volonghi I, Quatrale R, Benedetti F, Tecchio C. Wieczorek M, et al. Among authors: mosna f. Bone Marrow Transplant. 2022 Jul;57(7):1133-1141. doi: 10.1038/s41409-022-01690-x. Epub 2022 May 5. Bone Marrow Transplant. 2022. PMID: 35513485
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience.
De Bellis E, Imbergamo S, Candoni A, Liço A, Tanasi I, Mauro E, Mosna F, Leoncin M, Stulle M, Griguolo D, Pravato S, Trentin L, Lazzarotto D, Di Bona E, Bassan R, Lucchini E, Poiani M, Palmieri C, Zaja F. De Bellis E, et al. Among authors: mosna f. Leuk Res. 2022 Mar;114:106803. doi: 10.1016/j.leukres.2022.106803. Epub 2022 Feb 8. Leuk Res. 2022. PMID: 35150967 Free article.
Corrigendum to "Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience" [Leukemia Res. 114 (March 2022) 106803].
De Bellis E, Imbergamo S, Candoni A, Liço A, Tanasi I, Mauro E, Mosna F, Leoncin M, Stulle M, Griguolo D, Pravato S, Trentin L, Lazzarotto D, Di Bona E, Sancetta R, Lucchini E, Poiani M, Palmieri C, Zaja F. De Bellis E, et al. Among authors: mosna f. Leuk Res. 2022 Apr;115:106811. doi: 10.1016/j.leukres.2022.106811. Epub 2022 Feb 24. Leuk Res. 2022. PMID: 35219543 No abstract available.
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL).
Tisi MC, Ferrero S, Dogliotti I, Tecchio C, Carli G, Novo M, Stefani PM, Rattotti S, Balzarotti M, Marino D, Pelosini M, Romano A, Flenghi L, Zilioli VR, Calimeri T, Di Napoli A, Zanni M, Finolezzi E, Mosna F, Gini G, Mansueto G, Di Rocco A, Tomei G, Sgherza N, Olivieri J, Nassi L, Piazza F, Fama A, Greco A, Giannoccaro M, Mazzone AM, Visco C, Loseto G, Zaja F. Tisi MC, et al. Among authors: mosna f. Hemasphere. 2019 Oct 22;3(6):e305. doi: 10.1097/HS9.0000000000000305. eCollection 2019 Dec. Hemasphere. 2019. PMID: 31976479 Free PMC article.
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma.
Russignan A, Spina C, Tamassia N, Cassaro A, Rigo A, Bagnato A, Rosanò L, Bonalumi A, Gottardi M, Zanatta L, Giacomazzi A, Scupoli MT, Tinelli M, Salvadori U, Mosna F, Zamò A, Cassatella MA, Vinante F, Tecchio C. Russignan A, et al. Among authors: mosna f. Br J Haematol. 2017 Sep;178(5):781-793. doi: 10.1111/bjh.14771. Epub 2017 Jun 9. Br J Haematol. 2017. PMID: 28597546 Free article.
Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia.
Gottardi M, Mosna F, de Angeli S, Papayannidis C, Candoni A, Clavio M, Tecchio C, Piccin A, dell'Orto MC, Benedetti F, Martinelli G, Gherlinzoni F. Gottardi M, et al. Among authors: mosna f. Hematol Rep. 2017 Sep 26;9(3):7029. doi: 10.4081/hr.2017.7028. eCollection 2017 Sep 26. Hematol Rep. 2017. PMID: 29071049 Free PMC article. No abstract available.
Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent-thalassemia.
Quarta A, Sgherza N, Pasanisi A, Solfrizzi MP, Serra M, Vitucci A, Dello Iacono N, Renni R, Daprile C, Mosna F, Palma A, Frappampina R, Visceglie D, Pastore D. Quarta A, et al. Among authors: mosna f. Br J Haematol. 2020 Apr;189(2):e60-e63. doi: 10.1111/bjh.16468. Epub 2020 Mar 2. Br J Haematol. 2020. PMID: 32119115 Free article. No abstract available.
30 results